OCT for glaucoma: Today and tomorrow

Article

Comprehensive analysis helps with diagnosis and follow-up

Spectral-domain optical coherence tomography (SD-OCT) is now an established diagnostic tool for optic nerve diseases such as glaucoma. Since the first studies on glaucomatous eyes were published a decade ago using time-domain OCT (TD-OCT), remarkable advances have been realized.

Today ophthalmologists can use SD-OCT to investigate several parameters in cases with any degree of glaucoma. These are derived from the peripapillary retinal nerve fibre layer (RNFL), the optic nerve head (ONH) and the macular ganglion cells (GC). Comprehensive analysis of these data help the clinician in making the diagnosis and following patients up.

Peripapillary RNFL

Given the already good diagnostic capabilities of TD-OCT, it is not surprising that most studies performed with SD-OCT failed to detect any significant improvement when conventional circular peripapillary scans are used.1–4 The main advantage of SD-OCT is rather the remarkably improved repeatability of RNFL thickness measurements in both healthy and glaucomatous eyes, as shown by a test-retest variability which is half compared to that of TD-OCT.1,5 The main reason for such an improvement is related to the new acquisition protocols.

In the case of Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, California, USA), for example, the instrument does not just scan a circle around the ONH, but provides a tridimensional cube of peripapillary data; the 3.4 mm circular scan is subsequently extracted once the centre of the disc is automatically identified, so that the circle is automatically centred. By doing so the operator reduces the measurement variability typical of TD-OCT, where scan repeatability is strongly influenced by improper location of the circle around the ONH.6

It is important to highlight that the instruments manufactured by the different companies provide different, non-interchangeable measurements. Although only a few studies have directly compared some of these instruments,7,8 the published values clearly show that the algorithms developed by each manufacturer to identify and quantify the RNFL thickness are different. The 360° peripapillary RNFL thickness ranges between 89.8 and 113 microns.1,7–16 None of these measurements are interchangeable with those obtained by TD-OCT.

Compared to TD-OCT, one the main advancements of SD-OCT is represented by the RNFL thickness deviation map, which provides additional spatial and morphologic information about RNFL damage and improves the diagnostic sensitivity for glaucoma detection. Recent studies have demonstrated that the above-mentioned map has significantly higher value for diagnostic purposes compared to the standard circular scan.21,22

Last generation SD-OCT devices also offer the advantage of specifically designed software to assess glaucoma progression.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.